Your browser doesn't support javascript.
loading
Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.
Murata, M; Ikegame, K; Morishita, Y; Ogawa, H; Kaida, K; Nakamae, H; Ikeda, T; Nishida, T; Inoue, M; Eto, T; Kubo, K; Sakura, T; Mori, T; Uchida, N; Ashida, T; Matsuhashi, Y; Miyazaki, Y; Ichinohe, T; Atsuta, Y; Teshima, T.
Afiliação
  • Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Morishita Y; Department of Internal Medicine, Holy Spirit Hospital, Nagoya, Japan.
  • Ogawa H; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Kaida K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Nakamae H; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nishida T; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Inoue M; Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Kubo K; Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Sakura T; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Ashida T; Division of Hematology and Rheumatology, Department of Internal Medicine, Kinki University, School of Medicine, Osakasayama, Japan.
  • Matsuhashi Y; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
  • Miyazaki Y; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Teshima T; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Bone Marrow Transplant ; 52(2): 252-257, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27869808
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência a Medicamentos / Sistema de Registros / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Soro Antilinfocitário Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência a Medicamentos / Sistema de Registros / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Soro Antilinfocitário Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão